What is the appropriate management for an adult patient with an infundibular origin of the left posterior communicating artery (PCOM), considering the risk of cerebral aneurysm formation and cerebrovascular events?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Infundibular Origin of Left PCOM

An infundibular origin of the left posterior communicating artery requires serial imaging surveillance with MRA or CTA at yearly intervals, particularly if the infundibulum measures ≥3 mm in diameter, as these lesions can progress to true aneurysms with rupture risk. 1, 2

Understanding the Clinical Entity

An infundibulum is a funnel-shaped symmetrical enlargement at the origin of a cerebral artery, most commonly occurring at the PCOM-ICA junction, and is found in 7-25% of normal angiograms. 3 While traditionally considered a benign anatomical variant, documented cases demonstrate progression from infundibulum to saccular aneurysm formation with subsequent rupture. 1, 2, 3

Risk Stratification for Progression

High-risk features requiring more aggressive surveillance include:

  • Infundibulum diameter ≥3 mm - this threshold warrants mandatory follow-up imaging 1
  • Presence of other intracranial aneurysms - significantly increases risk of infundibulum-to-aneurysm progression 1
  • History of de novo aneurysm formation - indicates predisposition to aneurysm development 1
  • Family history of intracranial aneurysms - genetic susceptibility factor 1
  • Uncontrolled hypertension - hemodynamic stress accelerates progression 2
  • Well-developed PCOM with large ICA-PCOM angle - creates increased hemodynamic stress 2

Surveillance Protocol

For infundibula ≥3 mm or with high-risk features:

  • Perform baseline MRA or CTA to establish morphology and exact measurements 1
  • Repeat imaging at yearly intervals to detect early aneurysm formation 1
  • More stringent follow-up (potentially every 6 months) is warranted in patients with multiple aneurysms, documented de novo aneurysm formation, or familial aneurysm occurrence 1
  • Serial imaging should specifically assess for development of asymmetric outpouching or saccular projection from the infundibular wall 2

For infundibula <3 mm without high-risk features:

  • Consider baseline imaging and extended interval surveillance (every 2-3 years) given the lower but documented risk 1, 3

Medical Management

Aggressive cardiovascular risk factor modification is essential:

  • Blood pressure control is critical, as hypertension accelerates hemodynamic stress and aneurysm formation from infundibula 2
  • Standard atherosclerotic risk factor management including lipid control, smoking cessation, and diabetes management 4
  • Consider antiplatelet therapy (aspirin 75-325 mg daily) given the posterior circulation location and potential for thromboembolic complications 4

When to Intervene

Treatment becomes indicated when:

  • Documented progression to saccular aneurysm - any asymmetric outpouching or saccular projection requires treatment consideration 1, 2, 3
  • Development of symptoms (third nerve palsy, mass effect) - indicates growth and warrants urgent treatment 5
  • Aneurysm formation in posterior circulation location - even small posterior circulation aneurysms (<7 mm) carry 2.5% annual rupture risk compared to near 0% for anterior circulation 6

Treatment Modality Selection

If progression to true aneurysm occurs:

  • Endovascular coiling is preferred for posterior circulation aneurysms when technically feasible, based on improved functional outcomes 6
  • Surgical clipping remains an option for lesions not amenable to endovascular treatment 2
  • Both endovascular and neurosurgical evaluation should be obtained 6

Critical Pitfalls to Avoid

  • Do not dismiss infundibula as purely benign variants - documented cases of rupture exist, with fatal outcomes reported 3
  • Do not rely on single imaging study - progression occurs over years (documented cases show 7-year evolution), requiring serial surveillance 1
  • Do not use ultrasound alone - MRA or CTA provides superior visualization of posterior circulation anatomy 4
  • Do not delay treatment once aneurysm formation is documented - rupture can occur from small aneurysms originating from infundibula (documented rupture of 1.5 mm aneurysm) 2

Patient Counseling

Patients should be informed that while most infundibula remain stable, documented progression to aneurysm formation and rupture exists, necessitating long-term surveillance. 1, 3 The importance of blood pressure control and adherence to imaging follow-up should be emphasized. 2

References

Guideline

Management of Hypoplastic Right Posterior Communicating Artery

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Brain Aneurysm Rupture Risk and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What are the guidelines for managing a 2mm posterior communicating artery aneurysm in the UK?
Does a patient presenting with stroke-like symptoms and a 2 mm left posterior communicating artery (PCA) aneurysm warrant a neurosurgery consult?
Does a 2mm posterior communicating artery (p-comm) infundibulum or aneurysm warrant a neurosurgery consult?
What is the diagnosis and treatment for a posterior communicating artery (PCA) aneurysm?
What is the role of dosulepin (tricyclic antidepressant) in managing osteoarthritis, particularly in older adults with potential comorbid conditions and a history of depression or chronic pain?
Is there a connection between migraines and the Mirena (levonorgestrel intrauterine device (IUD)) in women with a history of migraines?
What alternative phosphodiesterase type 5 (PDE5) inhibitor, such as Avanafil (Avanafil), Sildenafil (Sildenafil), or Vardenafil (Vardenafil), can be used for a patient with erectile dysfunction (ED) who is experiencing severe headaches while taking Tadalafil (Tadalafil) 5mg up to 4 tablets once daily?
What is the best next step for a 19-year-old patient with bilateral hand itching and rashes, likely due to irritant contact dermatitis?
Can a urinary tract infection with Morganella morganii and Enterococcus faecalis, presenting with costovertebral pain and a colonized urinary catheter, affect the accuracy of a renal function scan?
What is the recommended restart dose for a patient with a history of taking Zyprexa (olanzapine) 5mg in the morning and 10mg at bedtime, who has not taken the medication in 3 months?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.